Takeda seeks to acquire outstanding shares of IDM Pharma

OSAKA, Japan Japanese drug maker Takeda Pharmaceutical Co. plans to acquire a company that develops cancer drugs.

Takeda announced Tuesday that it had commenced an offer to acquire all outstanding shares of common stock of IDM Pharma for $2.64 per share.

The offer is set to expire at midnight, June 23.